文章摘要
黄勉君,刘甲兴,杨聪德,蔡智伟,谢显学.主动脉球囊反搏器植入术治疗急性左心衰的应用价值[J].,2017,17(22):4357-4360
主动脉球囊反搏器植入术治疗急性左心衰的应用价值
Application Values of Intraaortic Palloon Pumping in the Treatment of Acute Left Heart Failure
投稿时间:2016-10-24  修订日期:2016-11-20
DOI:10.13241/j.cnki.pmb.2017.22.038
中文关键词: 主动脉球囊反搏器植入术  急性左心衰  心功能  近期主要终点事件
英文关键词: Aortic balloon pump implantation  Acute left heart failure  Cardiac function  Recent primary end point event
基金项目:
作者单位E-mail
黄勉君 解放军第180医院心血管内科 福建 泉州 362000 huangmianjun_8502@medicinepaper.com.cn 
刘甲兴 解放军第180医院心血管内科 福建 泉州 362000  
杨聪德 解放军第180医院心血管内科 福建 泉州 362000  
蔡智伟 解放军第180医院心血管内科 福建 泉州 362000  
谢显学 解放军第180医院心血管内科 福建 泉州 362000  
摘要点击次数: 270
全文下载次数: 176
中文摘要:
      摘要 目的:探讨主动脉球囊反搏器植入术治疗急性左心衰的应用价值。方法:收集我院2013年2月-2016年1月收治的急性左心衰患者102例作为本次研究对象,根据随机信封抽签的方法将患者分为观察组和对照组,每组51例。对照组给予常规药物治疗,观察组在常规药物治疗的基础上加用主动脉球囊反搏器植入术,记录与观察两组患者的临床结局。结果:观察组的总有效率为96.1%,显著高于对照组的总有效率84.3%(P<0.05)。治疗后,观察组与对照组的LVEF值分别为65.22±4.52%和58.20±5.31%,都明显高于治疗前的45.29±5.14%和45.20±4.89%,且观察组的LVEF值明显高于对照组(P<0.05)。观察组治疗后随访6个月的死亡、顽固性缺血、恶性心律失常等近期主要终点事件发生率为5.9%,对照组为21.6%,观察组明显低于对照组(P<0.05)。结论:主动脉球囊反搏器植入术治疗急性左心衰能促进左心室功能的改善,提高治疗效果,减少近期主要终点事件的发生。
英文摘要:
      ABSTRACT Objective: To evaluate the application values of intraaortic palloon pumping in the treatment of acute left heart failure. Methods: From February 2013 to January 2016, 102 patients in our hospital for diagnosis and treatment of acute left heart failure were selected as the research object, all the patients were equally divided into the observation group and control group with 51 patients in each group according to the random draw envelope principle. The control group was given routine drug treatment, the observation group was given intraaortic palloon pumping treatment based on the treatment in control group, the prognosis of two groups were observed and compared between two groups. Results: The total effective rate of observation group and control group were 96.1 % and 84.3 %, respectively, which was significantly higher in the tobservation group than that of the control group (P<0.05). The LVEF values in the observation group and control group after treatment were 65.22±4.52 % and 58.20±5.31 % respectively, which were significantly higher than those before treatment 45.29±5.14 % and 45.20±4.89 %, and the LVEF value of observation group was significantly higher than that of the control group (P<0.05). After 6 months' treatment, the incidence of death, refractory ischemia, malignant arrhythmia and other recent primary end points in the observation group was 5.9 %, the control group was 21.6 %, which was significantly higher than that of the observation group(P<0.05). Conclusion: Aortic balloon pump implantation could promote the improvement of left ventricular function, improve the treatment effect, reduce the occurrence of recent primary end point event in the treatment of acute left heart failure.
查看全文   查看/发表评论  下载PDF阅读器
关闭